Background: The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has presented various clinical challenges, including ocular manifestations. Understanding the prevalence and clinical characteristics of ocular symptoms in COVID-19 patients is crucial for comprehensive patient care and infection control. Objectives: This retrospective Study aimed to investigate ocular manifestations and clinical characteristics in a cohort of 38 COVID-19 patients admitted to the World College of Medical Science and Research Hospital in Haryana, India, from March 2020 to September 2020. Methods: Medical records were reviewed, and data on ocular symptoms, clinical characteristics, and laboratory findings were collected. Descriptive statistics and chi-squared tests were used for data analysis. Results: The findings revealed important insights into the patient demographics and clinical characteristics. Most patients were in the 31-40 age group (42.11%), and males constituted the majority (60.53%). Fever was the most common symptom (33.33%), followed by cough (25.64%), while severe disease severity prevailed (41.03%). Laboratory results indicated that lymphopenia (26.32%) and abnormal chest X-rays (31.58%) were relatively common, suggesting clinical significance. Elevated CRP levels (21.05%) and increased ferritin (21.05%) also featured prominently. These findings enhance our understanding of COVID-19 manifestations and patient profiles in this region. Conclusions: Ocular manifestations, particularly conjunctivitis, were observed in a significant proportion of COVID-19 patients in our Study. This underscores the importance of considering ocular symptoms in the clinical evaluation of COVID-19 cases. Additionally, the high prevalence of lymphopenia and elevated CRP levels suggests a potential association between ocular involvement and systemic inflammation in COVID-19 patients.